Nuveen Asset Management
ALNY icon

Nuveen Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$106M Buy
448,881
+7,789
+2% +$1.83M 0.03% 393
2024
Q3
$121M Sell
441,092
-147,377
-25% -$40.5M 0.03% 377
2024
Q2
$143M Buy
588,469
+76,491
+15% +$18.6M 0.04% 323
2024
Q1
$76.5M Sell
511,978
-31,433
-6% -$4.7M 0.02% 491
2023
Q4
$104M Sell
543,411
-3,047
-0.6% -$583K 0.03% 388
2023
Q3
$96.8M Sell
546,458
-6,221
-1% -$1.1M 0.03% 379
2023
Q2
$105M Sell
552,679
-56,427
-9% -$10.7M 0.04% 373
2023
Q1
$122M Sell
609,106
-9,538
-2% -$1.91M 0.05% 329
2022
Q4
$147M Sell
618,644
-15,974,624
-96% -$3.8B 0.06% 295
2022
Q3
$3.32B Buy
16,593,268
+16,296,223
+5,486% +$3.26B 1.35% 7
2022
Q2
$43.3M Sell
297,045
-64,990
-18% -$9.48M 0.02% 608
2022
Q1
$58.8M Sell
362,035
-228,509
-39% -$37.1M 0.02% 572
2021
Q4
$100M Sell
590,544
-176,488
-23% -$29.9M 0.03% 442
2021
Q3
$145M Buy
767,032
+114,024
+17% +$21.5M 0.04% 343
2021
Q2
$111M Buy
653,008
+57,008
+10% +$9.66M 0.03% 444
2021
Q1
$84.1M Sell
596,000
-2,700
-0.5% -$381K 0.03% 512
2020
Q4
$77.8M Buy
598,700
+171,329
+40% +$22.3M 0.03% 513
2020
Q3
$62.2M Sell
427,371
-26,197
-6% -$3.81M 0.02% 503
2020
Q2
$67.2M Sell
453,568
-61,300
-12% -$9.08M 0.03% 476
2020
Q1
$56M Buy
514,868
+111,311
+28% +$12.1M 0.03% 460
2019
Q4
$46.5M Sell
403,557
-12,657
-3% -$1.46M 0.02% 707
2019
Q3
$33.5M Buy
416,214
+25,552
+7% +$2.05M 0.01% 864
2019
Q2
$28.3M Buy
+390,662
New +$28.3M 0.01% 963
2015
Q3
Sell
-53,550
Closed -$6.42K 1455
2015
Q2
$6.42K Buy
+53,550
New +$6.42K 0.03% 472
2015
Q1
Sell
-109,216
Closed -$10.6M 1505
2014
Q4
$10.6M Sell
109,216
-94,984
-47% -$9.21M 0.06% 368
2014
Q3
$15.9M Buy
204,200
+28,348
+16% +$2.21M 0.1% 278
2014
Q2
$11.1M Buy
175,852
+4,073
+2% +$257K 0.07% 346
2014
Q1
$11.5M Buy
171,779
+121,236
+240% +$8.14M 0.07% 326
2013
Q4
$3.25M Sell
50,543
-4,368
-8% -$281K 0.02% 581
2013
Q3
$3.52M Buy
+54,911
New +$3.52M 0.02% 553